Real Time Monitoring of Prescription Opioid and Cannabis Co-Use in Patients with Chronic Pain
实时监测慢性疼痛患者处方阿片类药物和大麻的共同使用
基本信息
- 批准号:9893084
- 负责人:
- 金额:$ 20.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-03-15 至 2022-02-28
- 项目状态:已结题
- 来源:
- 关键词:AddressAdherenceAdultAffectAlcohol or Other Drugs useAlcoholsAmericanApplications GrantsBehaviorCannabinoidsCannabisCellular PhoneCharacteristicsClinical Practice GuidelineControl GroupsCorrelation StudiesCross-Sectional StudiesDataData CollectionDiabetes MellitusDropsEcological momentary assessmentEnvironmentFeedbackGeneral PopulationGoalsGrainGrantHealth BenefitHeart DiseasesIndividualInterventionInterviewLongitudinal StudiesMalignant NeoplasmsMeasuresMedical MarijuanaMethodsNational Institute of Drug AbuseObservational StudyOpioidOpioid RotationOutcomePainPain managementParticipantPatient Self-ReportPatientsPatternPhasePilot ProjectsPoliciesPopulationPopulation StudyProceduresProtocols documentationPublic HealthReportingResearchResearch PersonnelResearch Project GrantsStrategic PlanningStressSurveysTarget PopulationsTimeTobaccoWorkassociated symptombasechronic painchronic pain managementchronic pain patientcognitive interviewepidemiology studyevidence baseexperiencefollow-upinterestmarijuana legalizationmarijuana usemarijuana usernon-opioid analgesicnovelopioid epidemicopioid overdoseopioid sparingopioid useopioid use disorderopioid userpain patientpain reliefpain symptompatient registryprescription opioidprescription opioid misuseprotocol developmentreal time monitoringrecruityoung adult
项目摘要
PROJECT SUMMARY
The opioid epidemic in the US is associated with a dramatic increase in problematic opioid use and
overdoses. Chronic pain affects over 100 million Americans and opioids are frequently prescribed to aid
patients in managing pain. Approximately 25% of patients with chronic pain misuse prescription opioids and
approximately 10% have opioid use disorder (OUD).
Clinical practice guidelines stress the importance of non-opioid medications or non-pharmacological
interventions for chronic pain and recent population-based studies suggest that patients use cannabis for pain
relief. There is considerable interest in determining whether cannabis and cannabinoid products are viable
alternatives to opioids for pain management. However, the potential opioid-sparing effect of cannabis is based
primarily on studies of correlational findings that are limited by retrospective recall bias. Researchers have
noted the need for intensive longitudinal studies on near real-time co-use of these substances and pain
symptoms in the natural environment. A novel method to evaluate opioid and cannabis use patterns among
patients with chronic pain is Ecological Momentary Assessment (EMA). EMA is ideally suited to collect fine-
grained data on substance use and pain, with low recall bias and high ecological or real-world validity.
The overarching goal of this R21 exploratory research grant application is to conduct a smartphone-based
real-time observational study using EMA to investigate the relationship between opioid use, cannabis use, and
chronic pain.
We have assembled a strong team of investigators with critical expertise in EMA, opioid and cannabis
research, and chronic pain. Our preliminary studies have shown that we can conduct EMA studies focusing on
substance use and co-use with different populations. Moreover, we have demonstrated that many cannabis
users report chronic pain as the most important reason for their cannabis use. We have also demonstrated that
there is substantial day-to-day variability in pain and opioid use among patients with chronic pain and may be
influenced by factors other than their prescriptive plan.
The specific aims of this project are to: 1) Develop an EMA data collection protocol and investigate
participant adherence among chronic pain patients who are using opioids and cannabis. 2) Explore the
temporal interplay of cannabis and opioid use on a day-by-day level and associations between use of these
substances and pain ratings. To attain these aims, we will conduct a study consisting of 2 phases. Phase 1 will
conduct cognitive interviews to refine EMA measures and pilot a 14-day EMA data collection with N=20
participants, including follow-up interviews. EMA questions will be refined and clarified based on participant
feedback. Phase 2 will consist of a 30-day EMA data collection with N=100 chronic pain participants.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Johannes Thrul其他文献
Johannes Thrul的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Johannes Thrul', 18)}}的其他基金
Development of a Longitudinal Observational Research Registry for the Study of Medicinal Cannabis Use and Health
开发药用大麻使用和健康研究的纵向观察研究登记册
- 批准号:
10741486 - 财政年份:2023
- 资助金额:
$ 20.47万 - 项目类别:
Testing the impact of smartphone-based messaging to support young adult smoking cessation
测试基于智能手机的消息传递对支持年轻人戒烟的影响
- 批准号:
10404675 - 财政年份:2020
- 资助金额:
$ 20.47万 - 项目类别:
Testing the impact of smartphone-based messaging to support young adult smoking cessation
测试基于智能手机的消息传递对支持年轻人戒烟的影响
- 批准号:
10237932 - 财政年份:2020
- 资助金额:
$ 20.47万 - 项目类别:
Testing the impact of smartphone-based messaging to support young adult smoking cessation
测试基于智能手机的消息传递对支持年轻人戒烟的影响
- 批准号:
10633099 - 财政年份:2020
- 资助金额:
$ 20.47万 - 项目类别:
相似海外基金
Structural Racism, Pharmacy Closures and Disparities in Medication Adherence Among Older Adult Medicare Part-D Beneficiaries
结构性种族主义、药房关闭以及老年人医疗保险 D 部分受益人的药物依从性差异
- 批准号:
10568717 - 财政年份:2023
- 资助金额:
$ 20.47万 - 项目类别:
Medication Adherence and Cardio-Metabolic Control Indicators among Adult American Indians Receiving Tribal Health Services
接受部落卫生服务的成年美洲印第安人的药物依从性和心脏代谢控制指标
- 批准号:
10419967 - 财政年份:2022
- 资助金额:
$ 20.47万 - 项目类别:
Medication Adherence and Cardio-Metabolic Control Indicators among Adult American Indians Receiving Tribal Health Services
接受部落卫生服务的成年美洲印第安人的药物依从性和心脏代谢控制指标
- 批准号:
10592441 - 财政年份:2022
- 资助金额:
$ 20.47万 - 项目类别:
Leveraging Technology to Improve Medication Adherence in Adolescent and Young Adult Kidney or Liver Transplant Recipients
利用技术提高青少年和年轻肾移植或肝移植受者的药物依从性
- 批准号:
10369750 - 财政年份:2021
- 资助金额:
$ 20.47万 - 项目类别:
Leveraging Technology to Improve Medication Adherence in Adolescent and Young Adult Kidney or Liver Transplant Recipients
利用技术提高青少年和年轻肾移植或肝移植受者的药物依从性
- 批准号:
10633248 - 财政年份:2021
- 资助金额:
$ 20.47万 - 项目类别:
Leveraging Technology to Improve Medication Adherence in Adolescent and Young Adult Kidney or Liver Transplant Recipients
利用技术提高青少年和年轻肾移植或肝移植受者的药物依从性
- 批准号:
10487516 - 财政年份:2021
- 资助金额:
$ 20.47万 - 项目类别:
Mhealth for Pre-exposure Prophylaxis Adherence by Young Adult MSM
Mhealth 促进年轻 MSM 遵守暴露前预防
- 批准号:
10228564 - 财政年份:2018
- 资助金额:
$ 20.47万 - 项目类别:
Mhealth for Pre-exposure Prophylaxis Adherence by Young Adult MSM
Mhealth 促进年轻 MSM 遵守暴露前预防
- 批准号:
9347041 - 财政年份:2017
- 资助金额:
$ 20.47万 - 项目类别:
Mindfulness training with HIV-positive youth and adult family members to improve treatment adherence
对艾滋病毒呈阳性的青少年和成年家庭成员进行正念训练,以提高治疗依从性
- 批准号:
9480702 - 财政年份:2016
- 资助金额:
$ 20.47万 - 项目类别:
Mindfulness training with HIV-positive youth and adult family members to improve treatment adherence
对艾滋病毒呈阳性的青少年和成年家庭成员进行正念训练,以提高治疗依从性
- 批准号:
9906853 - 财政年份:2016
- 资助金额:
$ 20.47万 - 项目类别:














{{item.name}}会员




